-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Lung cancer
NCCNClinical Practice Guidelines for Non-Small Cell Lung Cancer 2022.
5 Edition(1)(Chinese)
NCCNClinical Practice Guidelines for Non-small Cell Lung Cancer 2022.
5 Edition (2) (Chinese)
NCCNNon-small cell lung cancer guide mind map (1) (2021.
7 version)
NCCNNon-small cell lung cancer guide mind map (2) (2021.
7 edition)
Non-small cell lung cancer, a competition of treatment options at home and abroad (2022.
5 version)
NCCNClinical Practice Guidelines for Small Cell Lung Cancer 2023.
1 Edition (Chinese)
NCCNSmall Cell Lung Cancer Guide Mind Map (2022.
2 Edition)
Small cell lung cancer, a big competition of treatment options at home and abroad (2023.
1 edition).
Fleischner guidelines: Management of incidental pulmonary nodules detected by CT (1) (Chinese)
Fleischner guidelines: management of incidental pulmonary nodules detected by CT (2) (Chinese)
NCCNClinical Practice Guide: Lung Cancer Screening 2022.
1 Version (Chinese)
Solid tumors
NCCNGlioma Patient Guide 2021 Edition (Chinese)
NCCNClinical Practice Guidelines for Head and Neck Cancer 2022.
2 Edition(1) (Chinese)
NCCNClinical Practice Guidelines for Head and Neck Cancer 2022.
2 Edition (2) (Chinese)
NCCNBreast Cancer Clinical Practice Guidelines 2022.
2 Edition (Chinese)
NCCNThymoma and thymic cancer clinical practice guidelines 2022.
1 version (Chinese).
NCCNClinical Practice Guidelines for Malignant Pleural Mesothelioma 2021.
1 Edition (Chinese)
NCCNClinical Practice Guidelines for Esophageal Cancer and Gastroesophageal Junction Cancer 2020.
4 Edition(1) (Chinese)
NCCNClinical Practice Guidelines for Esophageal Cancer and Gastroesophageal Junction Cancer 2020.
4 Edition(2) (Chinese)
NCCNGastric Cancer Clinical Practice Guidelines 2020.
3 (Chinese)
NCCNGastric Cancer Patient Guide 2019 Edition (Chinese)
NCCNColon Cancer Clinical Practice Guidelines 2021.
3 (Chinese)
NCCNClinical Practice Guidelines for Rectal Cancer 2020.
6 Edition(1) (Chinese)
NCCNClinical Practice Guidelines for Rectal Cancer 2020.
6 (2) (Chinese).
NCCNColorectal Cancer Screening Guidelines 2021 (Chinese)
NCCNProstate Cancer Clinical Practice Guidelines 2021.
2 Edition (Chinese)
NCCNMelanoma: Skin Clinical Practice Guidelines 2022.
2 (Chinese)
NCCNClinical Practice Guidelines for Soft Tissue Sarcoma 2020.
2 (Chinese)
tumor
NCCNClinical Practice Guidelines for Acute Lymphoblastic Leukemia 2020.
1 (Chinese)
NCCNClinical Practice Guidelines for Childhood Acute Lymphoblastic Leukemia 2022.
1 (Chinese)
NCCNClinical Practice Guidelines for Acute Myeloid Leukemia 2022.
2 (Chinese)
NCCNClinical Practice Guidelines for Chronic Myeloid Leukemia 2020.
2 (Chinese)
NCCNClinical Practice Guidelines for Hairy Cell Leukemia 2021.
1 (Chinese)
NCCNClinical Practice Guidelines for Multiple Myeloma 2022.
5 (Chinese)
NCCNHodgkin Lymphoma Clinical Practice Guidelines 2021.
4 (Chinese)
NCCNClinical Practice Guidelines for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2022.
3 (Chinese)
NCCNClinical Practice Guidelines for T-Cell Lymphoma 2021.
1 (Chinese)
NCCNClinical Practice Guidelines for Primary Cutaneous Lymphoma 2022.
2 (Chinese)
Adverse events
CTCAECommon adverse reactions in tumor treatment grade version 5.
0
NCCNGuidelines for the Management of Immunotherapy-Related Toxicities 2022.
1 (1)(Chinese)
NCCNGuidelines for the Management of Immunotherapy-Related Toxicities 2022.
1 (2)(Chinese)
NCCNAntiemetic Clinical Practice Guidelines 2022.
1 Version (Chinese)
NCCNClinical Practice Guidelines for Adult Cancer Pain 2022.
1 Edition(1)(Chinese)
NCCNClinical Practice Guidelines for Adult Cancer Pain 2022.
1 Edition(2)(Chinese)
NCCNHematopoietic Growth Factor Clinical Practice Guidelines 2022.
1 Edition (Chinese)
NCCNPrognosis of cancer-related infections Guidelines for Prevention and Treatment 2021.
1 (1)(Chinese)
NCCNGuidelines for the Prevention and Treatment of Cancer-Related Infections 2021.
1 (2)(Chinese)